Elucidation of apoptotic pathway of human B-cell lymphoma and its therapeutic application
Elucidation of apoptotic pathway of human B-cell lymphoma and its therapeutic application
批准号:
09670196
负责人:
ABE Masafumi
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We established a new human Burkitt's lymphoma cell line (HBL-9) which shows a unique feature of spontaneous apoptosis in vitro culture. The spontaneous apoptosis began at 36h after incubation and progressed rapidly. We analyzed bcl-2 family and caspases mainly using Western blot method to elucidate the signaling pathway for execution of spontaneous apoptosis of the HBL-9 cell line. Immunohistochemical stein and Western blot analysis revealed no expression of bcl-2 family (bcl-2, bcl-XィイD2LィエD2, bax and bad protein), Apaf-1, and cytochrome C on each harvested cell sample at the indicated times (0h, 12h, 24h, 36h, 48h). Western blot analysis revealed cleaved proteolytic fragments of caspase-2, caspase-3, caspase-8 at 36h and 48h after incubation but no cleaved proteolytic fragments of caspase-1, caspase-4, caspase-6, caspase-9, caspase-10. As protein substrates by caspase during the execution of spontaneous apoptosis, PARP, DF45/ICAD and lamin B were found but not lamin A. Caspase inhibitors Z-VAD-FMK and Asp-CHィイD22ィエD2-DCB inhibited both apoptosis and the processing caspase-2, caspase-3, caspase-7, caspase8, Caspase-2 inhibitors Ac-VDVAD-CHO and caspase-3/7 inhibitors Ac-DEVD-CHO inhibited the processing of caspase-2 and caspase-3 respectively but not apoptosis.These data indicates the following on the apoptotic pathway of HBL-9 cells;(1) The possibility that a signaling pathway, bcl-2 family→Apaf-1→cytochromeC→caspase-9, does not a company the execution phase of spontaneous apoptosis of HBL-9 cells.(2) The requirements for activations of at least four caspases (caspase-2, caspase-3, caspase-7 and caspase-8) for spontaneous apoptosis.(3) The possibility that a key effector protease upstream of caspase-2, caspase-3, caspase-7 and caspase-8.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studvofbioloeical function of CD10/NEP24.11 protein on the B-cells
-
批准号:17590310
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2005
-
负责人:ABE Masafumi
-
依托单位:
Molecular mechanism of the signaling pathway for execution of spontaneous apoptosis of human B-cell lymphoma
-
批准号:12670168
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:2000
-
负责人:ABE Masafumi
-
依托单位:
Establishment of SCID mouse metastatic model of human malignant lymphoma and analysis of lectin binding properties on metastatic capacity
-
批准号:07670209
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:ABE Masafumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
中药活性成分土木香内酯靶向 TXNL2 通过caspase-3/GSDME 介导的细胞焦亡抗未分化甲状腺癌的机制研究
-
批准号:ZCLQN26H2801
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:温庆良
-
依托单位:
壮骨止痛胶囊通过NLRP3/Caspase-1/GSDMD信号通路调控神经肽介导PMOP大鼠脑-肠-骨轴的机制研究
-
批准号:2026JJ81070
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈沙
-
依托单位:
骨痹汤调控NLRP3/ASC/Caspase-1介导的细胞焦亡治疗膝骨关节炎的作用及机制研究
-
批准号:2026JJ80380
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郑艳艳
-
依托单位:
TIRAP调控NLRP3/Caspase-1/GSDMD通路诱导KOA软骨细胞焦亡机制的研究
-
批准号:2026JJ81783
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖杰
-
依托单位:
FUNDC1介导的线粒体自噬通过ROS/NLRP3/Caspase-1调控PSD小胶质细胞焦亡的机制研究及中药干预
-
批准号:2026JJ82568
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:袁霞红
-
依托单位:
Caspase-6介导的NOL12酶切降解在脓毒症性肝损伤中调控巨噬细胞焦亡的机制研究
-
批准号:JCZRLH202600702
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“脑肠同调”理论从NLRP3/Caspase-1/GSDMD炎症通路探讨逍遥散对肝郁脾虚型FD大鼠的作用机制
-
批准号:2026JJ80620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺美燕
-
依托单位:
基于Caspase-1介导的焦亡探讨OSF癌变及加味丹玄口康纳米胶束干预机制
-
批准号:2026JJ81019
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李群
-
依托单位:
西维来司他钠通过抑制内皮细胞STING/caspase-1信号改善脓毒症血管高通透性的机制研究
-
批准号:2026JJ80584
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭甜
-
依托单位:
Prdx1通过Cathepsin B激活NLRP3/Caspase-1/GSDMD途径诱导结直肠癌细胞焦亡的作用机制研究
-
批准号:2025JJ60797
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何影
-
依托单位: